Leerink Partners analyst Richard Newitter reiterated an Outperform rating and boosted his price target on NuVasive (NASDAQ: NUVA) to $65.00 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Brean Capital Raises Price Target on NuVasive (NUVA) Following 2Q EPS BeatJuly 29, 2015 7:35 AM Northland Capital Markets Upgrades NuVasive (NUVA) to OutperformJuly 29, 2015 7:06 AM NuVasive (NUVA) Reports Settlement with DOJJuly 28, 2015 5:15 PM NuVasive (NUVA) Tops Q2 EPS by 6c; Enters Settlement with U.S. DOJJuly 28, 2015 4:39 PM NuVasive Announces Definitive Settlement With United StatesJuly 28, 2015 4:06 PM NuVasive Reports Second Quarter 2015 Financial ResultsJuly 28, 2015 4:05 PM